TG Therapeutics Inc (STU:NKB2)
€ 15.004 -0.278 (-1.82%) Market Cap: 2.33 Bil Enterprise Value: 2.24 Bil PE Ratio: 74.36 PB Ratio: 15.79 GF Score: 73/100

TG Therapeutics Inc at Bank of America Global Healthcare Conference Transcript

May 09, 2023 / 10:00PM GMT
Release Date Price: €29.79 (+0.98%)
Alec Warren Stranahan
BofA Securities, Research Division - Associate

Good afternoon, and welcome to day 1 of the 2023 BofA Health Care Conference. Thanks for joining the session with TG Therapeutics. My name is Alec Stranahan. I'm Vice President and Senior Biotech Analyst covering TG here at BofA. And I'm pleased to be joined today by Mike Weiss, Chairman, President and CEO of TG.

Thanks for being here, Mike.

Michael S. Weiss
TG Therapeutics, Inc. - Chairman, CEO & President

Yes. Appreciate it. Thanks for having me.

Alec Warren Stranahan
BofA Securities, Research Division - Associate

Yes. So I think Mike is going to run through some prepared remarks to start, and then we'll jump into Q&A.

So with that, Mike, over to you.

Michael S. Weiss
TG Therapeutics, Inc. - Chairman, CEO & President

So prepared would be an aggressive statement, but I'm going to say a few things about TG, just to orient everyone. And so yes, for those of you who are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot